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Abstract
Background: Prisons represent a unique opportunity to diagnose blood-borne viruses. Opt-out testing is receiving
increasing interest, as a result of mounting evidence to suggest that the manner in which a test offer is delivered,
affects test uptake. Although the effectiveness of opt-out testing within the prison setting has been established, robust
explanations are required for the variation in outcomes reported.
Methods: Rapid-realist review methodology was used to synthesise the literature on prison-based opt-out testing. The
review was carried out in three phases. Phase one: An expert panel provided literature relevant to the implementation
of opt-out testing within the English prison estate. Unstructured searches were also conducted to identify other social
programmes where “opt-out” had been used to increase uptake. Phase two: a systematic search of six peer-review and
five grey literature databases was carried out to identify empirical data on opt-out testing within the prison setting. Phase
three: Additional non-exhaustive searches were carried out to identify literature that reinforced emergent concepts. The
development of programme theory took place with each iteration and was validated in consultation with stakeholders.
Results: Programme theory was constructed for two outcomes: the proportion of intake offered a test and the
proportion offered that accepted testing. The proportion of intake offered testing was influenced by the timing of the
test offer, which was often delayed due to barriers to prisoner access. The decision to accept testing was influenced by
concerns about confidentiality, fear of a positive diagnosis, a prisoner’s personal interpretation of risk, discomfort with
invasive procedures, trust in healthcare, and the fidelity of the opt-out offer.
Conclusions: This review identified important implementation considerations that moderate the effectiveness of opt-out
testing programmes. It also highlighted a lack of appreciation for the theoretical underpinnings of opt-out programmes
and tension around how to implement testing in a manner that adheres to both default theory and informed consent. It
is anticipated that results will be used to inform the design and implementation of subsequent versions of these
programmes, as well as catalyse further in-depth analysis into their operation within the unique context of prison.
Review registration: CRD42017068342.
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Background
Hepatitis C (HCV), hepatitis B (HBV), and the human
immunodeficiency virus (HIV) are blood-borne viruses
(BBVs), which cause significant morbidity and mortality
globally. Biomedical innovation has provided effective
treatment options for infection with these BBVs [1]. How-
ever, in light of new global targets aimed at the elimination
of viral hepatitis by 2030 [2] and 90–90-90 HIV targets for
2020, the need for effective case-detection strategies is
becoming increasingly acute [1, 3].
Opt-out testing for BBVs has been suggested as a
method of case detection, in light of positive results from
other opt-out health programmes, such as opt-out organ
donation and opt-out antenatal HIV testing [4–6]. It
involves a subtle shift in the way the test offer is delivered
[7]. Unlike opt-in testing, opt-out does not require a
person to expressly agree to undergo a test, instead they
are notified that testing will be performed unless they
explicitly decline [8]. Opt-out therefore represents a more
paternalistic approach to eliciting consent [9].
Opt-out BBV testing has begun to filter into routine
medical practice, often targeted at high-risk communities
[7]. Prisons represent a particularly high-risk environment,
with the criminalisation of drug use and the association
between drug dependency and crime, elevating the preva-
lence of BBV infection [10, 11]. In response, the Centers
for Disease Control and Prevention has recommended
opt-out HIV testing within US prisons [11] and in 2014,
phased implementation of an opt-out testing strategy for
HIV, HCV, and HBV, developed by Public Health England
(PHE), the National Health Service England (NHSE), and
Her Majesty’s Prison and Probation Service (HMPPS),
began throughout the English prison estate [5]. Dried-
blood spot testing (DBST) has been recommended for use
in the English strategy, as it requires minimal training and
can be easier to perform for those with a history of inject-
ing drugs [12].
Systematic review evidence suggests that opt-out pro-
grammes can increase test uptake, when compared with
opt-in, whilst avoiding many of the ethical debates that
surround mandatory testing [13]. However, there exists
considerable variation in the way opt-out BBV test pro-
grammes are implemented and consequently the out-
comes produced [5, 13].
Although some explanations have been offered for these
different outcomes [7, 13], there remains little robust the-
ory to help better implement and run opt-out testing
programmes within prison. This review sought to remedy
this, by explaining how, why, for whom, and under what
conditions opt-out programmes testing for HIV, HCV, and
HBV within prison are likely to be effective [14, 15].
Results were targeted at the English prison estate, although
it was hoped that they would also serve as a general guide
for other programmes in other contexts.
Methods
This study utilised a rapid-realist review (RRR) approach
[16, 17]. The PROSPERO reference for the protocol is:
CRD42017068342. RAMESES reporting standards were
used to guide this study [17].
Realist methodology is increasingly being used to explore
the “black box” of complex health programmes, with the
aim of constructing an explanatory framework for how,
why, and when they work [18]. Applied to secondary re-
search, realist reviews have emerged as robust ways of
developing these insights [15, 16, 19]. However, realist
reviews are expansive and consequently resource intensive
[16]. Out of necessity, RRRs emerged as an alternative,
time-responsive, approach suited to small and emerging
bodies of literature, or as a first step of a multi-phase
project [16, 20, 21].
RRRs develop programme theory, an explanation for how
a programme brings about intended and unintended
changes to a social phenomenon within a given context
[18, 22, 23]. RRRs develop this theory by describing the
interaction between the programme’s context, the genera-
tive forces stimulated by the intervention (mechanisms),
and outcomes. Programme theory is therefore often
expressed using the Context-Mechanism-Outcome (CMO)
heuristic of realist evaluation [23]. As the constituents of
these CMOs can be interpreted in different ways, the re-
view team clarified their shared understanding early in the
review process (see glossary of terms in Table 1) [18, 22].
Review process
The RRR followed the broad steps detailed by Saul et al.
(2013). The review team began by securing support from the
London BBV Core Steering Group, a commissioning body
tasked with overseeing BBV service provision (including
opt-out testing) for the London prison estate. The group was
comprised of stakeholders from NHSE, PHE, HMPPS, the
Hepatitis C Trust, and representatives from the different
healthcare providers at each London prison, and therefore
acted as both an expert panel and reference group (providing
knowledge on current practice). Through collaboration with
the Steering Group, a series of research questions were
developed [16]:
1. “What are the key outcomes of public health interest,
from opt-out testing within a prison context?”
2. “What are the generative forces, catalysed by opt-out
testing programmes for BBVs within prison, that
produce these outcomes?”
3. “How does the physical and social context of
different prisons, influence the expression of these
generative forces?”
4. “What is recommended to improve these public
health outcomes?”
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To answer these questions, iterative searching was used
to construct, refine, and reinforce a programme theory for
opt-out BBV testing using the literature (Fig. 1) [15, 16].
As the search and analysis process varied between each
phase, it is described sequentially. All search results were
handled using MENDELY bibliographic software.
Phase one
In phase one, the review team narrowed the scope of the
review and developed a provisional programme theory [15,
16]. To do this, the Steering Group supplied the research
team with documents used in the development of the
English opt-out test programme [16]. In collaboration with
the Steering Group, a generic process for opt-out testing
was developed and two outcomes of public health interest
identified.
Provisional programme theory was then constructed
around these two outcomes. Documents sent by the Steer-
ing Group were supplemented with literature identified via
a series of unstructured searches, carried out on Google/
scholar and MEDLINE for previous programmes that used
opt-out to enhance uptake. Phase one articles did not
undergo a formal process of eligibility review or quality
appraisal, as they were only used to develop the framework
that structured subsequent review iterations [15].
Phase two
With the provisional programme theory developed, the re-
view team then conducted a systematic search for empirical
data to refine that theory. A structured search algorithm
was developed for bibliographic databases and piloted in
MEDLINE, in consultation with a database expert based at
the Royal Free London NHS Foundation Trust’s Medical
Library. Search terms focused on opt-out testing within a
prison context and were informed by Rumble’s et al. (2015)
search strategy for a systematic review of routine test
methods for BBVs in prison (Table 2) [13].
The search did not specify testing for HCV, HBV, or
HIV, meaning articles discussing cousin interventions,
which nonetheless could be useful for theory refinement,
would be identified [15]. MEDLINE, PsycInfo, EMBASE,
Scopus, CINHAL+, and ASSIA were all searched using
the systematic algorithm (amended as required for each
database) in June 2017 (Additional file 1). A search of
five grey literature databases (ProQuest Dissertations
and Theses Global, DART-Europe-E-Theses Portal,
Open Grey, Google Scholar, and “.GOV”) was also
carried out in June 2017 [18].
Search results underwent a formal process of eligibility
assessment and quality appraisal. Each stage was
conducted independently by at least two authors, with
Table 1 Glossary of terms
Term Definition
Realist review A theory-driven approach to synthesising secondary research (including quantitative, qualitative, or mixed
methods research). It aims to develop an explanatory model for how a programme (or different programmes)
bring about a recorded change, why, for whom, and under what circumstances. It does this by developing
realist programme theory, expressed as Context + Mechanism (Resource/Response) = Outcome.
Rapid-realist review (RRR) An adapted form of realist review, which provides a truncated method for the development of realist
programme theory, whilst preserving the core elements of realist methodology. It relies more explicitly on
stakeholders to focus and expedite the review process.
Programme theory An explanation for how a programme works. Realist reviews and RRRs attempt to develop and test
programme theory.
Provisional programme theory A hypothesised explanation for how a programme is expected to work. Realist reviews and RRR usually start
by developing a provisional programme theory to be tested using the literature.
Refined programme theory The product of a realist review or RRR. An explanation for how a programme works in practice, based on
empirical data identified by the review.
Context-mechanism-outcome (CMO)
configuration
A heuristic used in realist reviews or RRRs to structure an explanation for how a programme, or part of a
programme, works. CMO configurations act as the building blocks for programme theory.
Context Covers the programme context and the broader contextual backdrop that the programme is situated within,
which modify the expression of mechanisms [22].
Mechanism The “underlying entities, processes or social structures, which operate in particular contexts to generate
outcomes of interest” [18]. This review focused on the individual reasoning and preference construction,
which occurred in response to resources implemented by the opt-out testing programme [79].
Outcome Both the intended and unintended consequences of the opt-out testing programme. Outcomes can be
proximal, intermediate, or final [22].
Nudge Theory Nudge is a “substantive theory” (i.e. a theory that exists within a discipline, which can be used to help
understand the way a programme works). Utilised in the fields of behavioural science and economics, it
describes various quirks of human behaviour and decision-making and suggests ways these can be used to
encourage certain actions.
Default Effect A theory within Nudge, which suggests that for any choice or action, there is a tendency for the majority of
individuals to stick with the default option.
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disagreements resolved by discussion with a third author.
Citations had titles and abstracts reviewed against the fol-
lowing criteria: “Does the citation indicate a prison
context?”; “Does the citation indicate testing for a physical
disease?”; and “Does the citation discuss physical disease in
a population not an individual?”
Any citations that failed to answer “yes” to these ques-
tions were excluded. Citations then had their full-text
downloaded and were assessed against three dimensions of
relevance: “Provides information related to mechanisms
triggered by opt-out testing”; “Provides information on
outcomes of opt-out testing”; “Provides contextual informa-
tion related to opt-out testing within prisons”.
Articles that did not provide information on one of
these dimensions were excluded. A traffic light system
was then used to highlight how many dimensions were
covered by each article (red articles covered one dimen-
sion, orange two, and green three). Each reviewer also
assigned articles a subjective score from 1 to 10, to indi-
cate how useful they believed it would be in the analysis.
An average of the two reviewers’ scores was taken and
assigned alongside the colour, enhancing transparency,
and allowing for some prioritisation of articles. Articles
designated red and with a low score (≤4), were reviewed
by authors again and their inclusion discussed.
The Mixed Methods Quality Appraisal Tool [24] was
used for quality assessment of primary research and the
Critical Appraisal Skills Programme: Systematic Review
Checklist for systematic reviews. The unit of analysis
was the contributing evidence, although an overall qual-
ity score was assigned [15]. If a piece of information
within an article was deemed low quality, it was
excluded, but other pieces of data of acceptable quality
were retained from the article [15, 19]. As grey literature
and literature review articles did not undergo quality
assessment, data on context and mechanism were
included if it was supported by, or consistent with, data
Fig. 1 Review process used to develop a refined programme theory for opt-out BBV testing within prison
Table 2 Population, location, exposure table, summarising
search terms used during the systematic search of online
databases
Population Location Exposure
• Prisoner*
• Offender*
• Convict*
• Detainee*
• Inmate*
• Incarcerated
• Prison*
• Gaol*
• Jail*
• Penal institution*
• Correction* or penal
or remand* or detention
or custody) adj2
(centre or department
or facility* or system*)
• Penitent*
• Mass screen*
• (Mandatory or systematic
or routine or compulsory
or obligatory) adj (test* or
screen* or diagnos* or
identif* or assess)
• Opt-out
• Opt* out
Word root searching (denoted using the symbol “*”) was frequently used to
find variant forms of a single word
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from other empirical articles, but quantitative outcomes
were not used.
Data from articles were annotated and coded as either
context, mechanism, or outcome. This evidence was
then grouped into a realist matrix, allowing for theming
across the matrix [25]. Data was synthesised with the
provisional programme theory developed during phase
one, via a process of adjudication and amalgamation,
producing a refined list of CMO configurations (CMOc)
[15]. These were discussed in data meetings with authors
and validated during meetings with the expert panel and
reference group [16]. One author also observed staff
training and opt-out testing conducted within two
English prisons, further helping validate CMOcs.
Phase three
Following phase two, a refined programme theory had
begun to take shape. However, to further reinforce the
CMOcs developed, a series of purposive unstructured
searches were undertaken on MEDLINE and Google/
scholar [18, 26]. Searches primarily focused on acquiring
qualitative and theoretical articles, discussing testing for
BBVs in prison and non-prison settings. It was not an
exhaustive process, but aimed to purposefully draw
together a diverse range of literature, which was then
used to reinforce the theoretical “backbone” of the
refined programme theory [26].
Phase three articles did not undergo a formal process
of eligibility assessment, but were assessed for quality
using the Mixed Methods Quality Appraisal Tool [24].
They did not contribute evidence to outcomes, but were
included as they reinforced aspects of context and
mechanism [26].
Results
The expert panel supplied the research team with 26
documents and 18 articles were identified via unstruc-
tured searching (Fig. 2). A further 3435 citations were
identified via database searching and 663 through grey
literature searching. After duplicates were removed,
3381 titles and abstracts were screened, and 457 articles
remained for full-text review. 11 documents from the
expert panel and 9 articles from the unstructured search
(Additional file 2) were used in framework, process, and
provisional programme theory development. 29 empir-
ical articles (Table 3) were used in programme theory
refinement. These were supplemented with a further 11
articles identified through purposive unstructured
searching (Additional file 3).
Process theory and contextual framework
Reports identified by the expert panel were used to develop
a generic process for opt-out testing (Additional file 4). A
range of potential outcomes of public health interest were
identified. The research team focused on the proportion of
intake offered a test and the proportion offered that ac-
cepted testing, as these outcomes were highlighted by the
Steering Group as key targets for the opt-out intervention
[16, 27]. A framework was also developed, to aid the re-
search team conceptualise the sphere of contextual influ-
ences that could affect these outcomes (Fig. 3).
Provisional programme theory
Using data from phase one, provisional programme
theory was constructed around the two outcomes
selected (Fig. 4).
It was hypothesised that the timing of the test offer
would influence the proportion of prisoners offered a
test [28–30].
In terms of test uptake, educational information cover-
ing transmission risk, symptoms, and the importance of
testing was anticipated to play a priming role during the
test offer, helping prisoners more accurately interpret
their risk of infection and assess costs and benefits of
testing [31].
The way testing was offered was also expected to influ-
ence uptake. Offering testing in an opt-out manner is not
be the norm for health workers, therefore training was
considered essential to ensure test offers were opt-out in
practice (Fig. 4) [32].
Finally, the unstructured searches carried out during
phase one, found literature that suggested the Default Ef-
fect, a component of Nudge Theory, underpinned opt-out
[18, 25]. The Default Effect suggests that for any choice or
action, there is a tendency for individuals to stick with the
default option [4]. By aligning the default option of a BBV
testing programme with the public health objective (pris-
oner takes a test), opt-out was hypothesised to encourage
test uptake in a variety of ways [4, 33, 34]:
1. Switching cost: Individuals incur a cost
(e.g. having to justify decision or fill out a form)
when opting-out of testing. If this cost exceeds
the benefit of opting out, then it is irrational for
the individual to do so [35].
2. Loss aversion: Individuals tend to weight losses
more heavily against equivalent gains. By making
testing the default option, loss of benefits provided
by testing are weighted more heavily against
potential gains of not testing [36].
3. Cognitive effort: Making an active decision
requires cognitive effort. By making testing the
default option, opt-out testing exploits individuals
bias not to expend this effort, encouraging those
who do not exhibit a strong preference to test [35].
4. Recommendation: Making testing the default
option, acts as an implicit or inferred
recommendation to test [4, 36].
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Refined programme theory
6 CMOcs for the proportion offered testing and 7 for test
uptake are presented. Additional file 5 contains the full list
of CMOcs developed from the RRR.
Under each CMOc, background information is pro-
vided. The configuration is then presented in italics, with
components explicitly highlighted: C = context, MR =
mechanism resource, MRE =mechanism reasoning re-
sponse and O = outcome. Exemplifying data, where avail-
able, is then presented, providing the reader access to
empirical evidence that contributed to theory develop-
ment and refinement. As reported in other realist reviews,
empirical evidence rarely presented a clear description of
all three constituents, making abductive reasoning critical
to ensure complete CMOc articulation.
Proportion offered testing
There was significant variation in the proportion offered test-
ing between different prison-based opt-out programmes,
ranging from 13 to 100% [13, 37–43]. Failure to offer testing
was an implementation issue, operating at various concep-
tual levels of prison context (Fig. 3).
CMOc 1: Delayed test offer
The timing of the test offer was a salient factor affecting the
proportion offered testing [5, 11, 13, 39, 42–47]. When
Fig. 2 Flow diagram detailing the search results of the rapid-realist review. Diagram design guided by recommendations made by the PRISMA
Group (2009) [80]
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Table 3 Characteristics of phase 2 studies, summarising first author/year, country, prison, disease, study design, method of data
collection, aims of research, relevance, and quality assessment score (acceptable: b, good: c, excellent: d
First author, year Country Prison Disease Study design Data
collection
Aims Dimensions
of relevance
Strength
of relevance
Quality
score
Kavasery, 2009 [43] U.S. Urban men’s
jail – New
Haven
Connecticut
HIV Prospective
controlled
trial
Quantitative
data capture
Determine the
optimal timing
of opt-out HIV
testing for
newly incarcer
ated jail
detainees.
Red
Orange
Green
9 d
Beckwith, 2011 [41] U.S. Rhode
Island Jail
HIV Mixed-methods:
sequential
explanatory
Routine data
and interviews/
FGD
Introduce rapid
opt-out HIV test
ing to Rhode Is
land Jail.
Red
Orange
Green
8 d
Public Health
England, 2015 [5]
U.K. Mixture of
phase 1
“pathfinder”
prisons
HIV, HCV,
and HBV
Project
evaluation
Questionnaire Evaluation of
opt-out testing
for blood borne
viruses, imple
mented
throughout pilot
English prisons.
Red
Orange
4 N/A
Elkington, 2016 [59] U.S. Mixed HIV Literature
review
Systematic
search
To review the
effectiveness of
HIV testing and
linkage
programmes
and review
barriers and
facilitators to
these
programmes in
the correctional
setting.
Red
Orange
4 N/A
Rosen, 2016 [52] U.S. North
Carolina
HIV Before and
after study
Routine data Assess the
impact of
routine opt-out
testing in terms
of case detection.
Red 5 d
Rice, 2011 [44] U.S. Wayne
County Jail
HIV Thesis Multiple Design,
implement, and
evaluate a jail-
based HIV testing
program.
Red
Orange
Green
10 N/A
Spaulding, 2015 [38] U.S. Fulton
County Jail
HIV Mixed-methods:
sequential
explanatory
Routine data
and
questionnaire
To establish a
rapid opt-out HIV
testing program,
led by the jail-
based nursing
team.
Red
Orange
Green
6 c
Lucas, 2016 [39] U.S. Eight prison
reception
centres
(California)
HIV Quantitative
descriptive
evaluation
Routine data Conduct an
evaluation of
routine HIV
services,
implemented
throughout
California.
Red 4 c
Rosen, 2007 [63] U.S. 8 intake
prisons in
North
Carolina
HIV Thesis Routine data Evaluation of a
large southern
state opt-out HIV
testing
programme.
Red
Orange
Green
5 N/A
Schoenbachler,
2016 [55]
U.S. Durham
County Jail,
Florence
Detention,
Orangeburg
Jail, Marion
Jail and
HCV Quantitative
descriptive
evaluation
Routine data Evaluate an HCV
testing and
linkage-to-care
post release
program among
detainees of
small-to-medium
Red
Orange
5 b
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Table 3 Characteristics of phase 2 studies, summarising first author/year, country, prison, disease, study design, method of data
collection, aims of research, relevance, and quality assessment score (acceptable: b, good: c, excellent: d (Continued)
First author, year Country Prison Disease Study design Data
collection
Aims Dimensions
of relevance
Strength
of relevance
Quality
score
Darlington Jail sized jails.
Grinstead, 2003 [64] U.S. Mixed HIV, HCV,
HBV, and
other
sexually
transmitted
infections
Qualitative
exploration
Interviews Explore
providers’
experiences
regarding HIV,
hepatitis, and
other sexually
transmitted
infection testing
services within
prison.
Red
Orange
7 c
Centres for Disease
Control, 2011 [49]
U.S. Washington
State
Department of
Corrections (12
male facilities)
HIV Quantitative
descriptive
evaluation
Routine data To assess the
rate of testing
under three
different testing
strategies: on-
request, routine
opt-in, and rou
tine opt-out.
Red
Orange
Green
5 c
Centres for Disease
Control, 2009 [11]
U.S. N/A HIV Opt-out testing
programme
guidance
N/A To guide the
implementation
of opt-out HIV
testing in the
correctional
setting by
highlighting
suggested
common
components and
tenants of such
a testing
programme.
Red
Orange
6 N/A
Peter, 2009 [45] U.S. Orleans
Parish
Prison,
Jefferson
Parish
Correctional
Centre
HIV Thesis Routine data Look at the
effectiveness of
opt-out and opt-in
approaches to HIV
testing in jail
populations.
Red
Orange
7 N/A
Muessig, 2016 [57] U.S. North
Carolina
State Prison
System
HIV Qualitative Interviews –
76 incarcerated
men and
women
Exploring issues of
HIV stigma within
an opt-out testing
programme.
Red
Orange
Green
10 c
Walker, 2005 [54] U.S. N/A HIV Letter(s) N/A Discusses the
ethical concerns
surrounding
routine opt-out
HIV testing
within the
prison setting.
Red 4 N/A
Beckwith, 2010 [67] U.S. N/A HIV Literature
review
Search Provide a review
of the current
state of delivering
HIV testing,
prevention,
treatment and
transition services
to incarcerated
populations.
Red
Orange
4 N/A
Rosen, 2015 [8] U.S. North
Carolina
State Prison
System
HIV Quantitative
cross-sectional
survey
Quantitative
survey and
routine data
To explore
prisoners
understanding
of the voluntary
nature of routine
opt-out testing.
Red
Orange
8 c
Francis-Graham et al. BMC Health Services Research          (2019) 19:152 Page 8 of 18
Table 3 Characteristics of phase 2 studies, summarising first author/year, country, prison, disease, study design, method of data
collection, aims of research, relevance, and quality assessment score (acceptable: b, good: c, excellent: d (Continued)
First author, year Country Prison Disease Study design Data
collection
Aims Dimensions
of relevance
Strength
of relevance
Quality
score
Grodensky,
2016 [48]
U.S. North
Carolina
Prison
System
HIV Quantitative
cross-sectional
survey
Quantitative
survey and
routine data
Estimate the
proportion
unaware of being
tested and the
proportion of
people tested
who did not want
a test.
Red
Orange
Green
9 c
Cole, 2014 [46] U.S. Cook
County Jail
Chlamydia
trachomatis
& Neisseria
gonorrhoeae
Retrospective
analysis
Routine data Evaluate the
impact of opt-out
testing on rates of
testing and diag
nosis of infection
among incarcer
ated women, as
sess the propor
tion of infections
successfully
treated, and evalu
ate factors associ
ated with receipt
of treatment.
Red
Orange
Green
8 c
Public Health
England, 2016 [70]
U.K. Pentonville
Prison
HIV, HBV,
and HCV
Pilot evaluation Routine data Report results
from provisional
data analysis for
the pilot blood-
borne virus care
pathway trialled
within Pentonville
prison.
Red
Orange
5 N/A
Jack, 2016 [51] U.K. East
Midlands
Category B
male prison
HCV Qualitative
phenomenology
Interviews
(prison officers)
To explore the
views of prison
officers about
people in prison
being tested and
treated for HCV.
Red
Orange
6 d
Beckwith, 2012 [53] U.S. Baltimore
Department
of Corrections,
Philadelphia
Prison System,
District of
Columbia
Department of
Corrections
HIV Quantitative
descriptive
evaluation
Routine data To assess the
feasibility of
implementing
large scale rapid
and routine opt-
out testing pro
grammes for HIV
in large urban jails.
Red
Orange
Green
6 d
Centres for Disease
Control, 2013 [37]
U.S. Fulton
County Jail
HIV Quantitative
descriptive
evaluation
Routine Data Evaluate a routine
opt-out testing
programme in a
large county jail.
Red
Orange
Green
5 c
Centre for Disease
Control, 2010 [77]
U.S. Rhode
Island Jail
HIV Quantitative
descriptive
evaluation
Routine Data Review of
Rhode Island
Jail’s testing
records.
Red
Orange
4 c
Kavasery, 2009 [42] U.S. York
Correctional
Institution,
Connecticut
HIV Prospective
controlled trial
Quantitative
data capture
Evaluate the
optimal time to
conduct routine
opt-out HIV test
ing of newly incar
cerated jail inmates
in a manner that
maximises the
number of
individuals
capable of
consenting and
wiling to be
Red
Orange
Green
9 d
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prisoners first arrive, all new intake usually undergo a first
night health check. Seven studies reported opt-out testing
conducted during this process [8, 37, 38, 45, 46, 48]. Seven
other articles reported testing taking place anywhere between
3 and 14 days after first reception, often during a secondary
health check [39, 40, 44, 49–52]. Testing at a secondary
clinic often occurred because of a perceived lack of time dur-
ing the first night or because the first night health check was
reserved for dealing with urgent healthcare problems that
required immediate intervention [39, 40, 44, 49–52].
In a prison that has a rapid population turn-over (C),
a programme mandated delay in engaging intake with
an opt-out test offer (MR) reduces the proportion of in-
take offered a test (O), as some individuals have
already been released or transferred (C).
This was exemplified during Beckwith’s et al. (2012)
evaluation of rapid-HIV testing within three urban jails.
A 3–4 day delay in the Baltimore Department of Correc-
tions, resulted in a 13% test offer proportion compared
to 100 and 89% respectively in the Philadelphia Prison
System and District of Columbia Department of Correc-
tions, which offered testing during a first night health
check [53].
CMOc 2: Early testing and capacity to consent
The desirability of first night testing was tempered by
the need for informed consent [11, 37, 42, 43, 47, 54].
A higher proportion of prisoner’s lack capacity to
consent on the first night (e.g. undergoing substance
abuse withdrawal) (C). As opt-out testing requires
informed consent (C), health workers that identify
this lack of capacity (MR) and view it as important
(MRE) will not offer testing (O).
This was highlighted in two prospective control trials
conducted in US jails, which found 10–11% of new
intake were not medically competent to be tested imme-
diately upon entrance, limiting the utility of first night
testing [42, 43]. This dropped to 0–4% when testing took
place 1–7 days after first reception [42, 43].
CMOc 3: Prioritisation of security and prison processes
Prison officers were important gatekeepers, as they
tended to dictate prisoner movement within the prison
environment [44–46, 51, 55].
Prison officers have a challenging role, particularly
when budget cuts have strained the workforce (C). Opt-
out testing often requires prison officers to collect pris-
oners, bring them to clinic, and supervise them (MR).
Officers prioritise security and prison processes over
escorting and monitoring prisoners at clinic (MRE),
meaning prisoners frequently do not arrive, or are not
allowed to be at the clinic, to be offered testing (O).
This process of prioritisation was demonstrated in quotes
from qualitative work with prison officers: “the issue with
Table 3 Characteristics of phase 2 studies, summarising first author/year, country, prison, disease, study design, method of data
collection, aims of research, relevance, and quality assessment score (acceptable: b, good: c, excellent: d (Continued)
First author, year Country Prison Disease Study design Data
collection
Aims Dimensions
of relevance
Strength
of relevance
Quality
score
tested.
Newlan, 2016 [40] Indonesia Banceuy
Prison
HIV, HBV,
and HCV
Natural
experiment
Routine data To compare the
efficacy of two
different testing
strategies (routine
or targeted).
Red
Orange
Green
5 b
Rumble, 2015 [13] Mixed Mixed HIV, HBV,
and HCV
Systematic
review
Systematic
literature
search
Describe
components of
routine HIV, HBV,
and HCV testing
policies in prisons
and quantify
testing
acceptance,
coverage, result
notification, and
diagnosis.
Red
Orange
Green
7 d
Gagnon, 2012 [61] N/A N/A HIV Literature
review
Search Provide a
sociological
critique of
mandatory testing
in light of other
testing
approaches,
including opt-out.
Red
Orange
7 N/A
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Fig. 4 Provisional programme theory developed using articles acquired from phase one
Fig. 3 The different spheres of context, influencing the reasoning process of two key actors involved in the opt-out test offer
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the health should be considered, if its’ not life threatening..
.then security should be the priority” [51]. This was also
highlighted by health workers: “I think you can’t get away
from the fact that we’re entirely dependent on prison officers
to deliver healthcare services.. .We’ve lost, since I’ve been
here, 25% of prison officers.. .Who would have thought that
‘do not attends’ are a massive problem in prison?” [30].
CMOc 4: Provider capacity to run clinics
Stretched health teams meant that testing clinics could
not be properly run, resulting in prisoners being missed
[5, 11, 47, 56].
Prisons are a demanding place to work (high burden
of mental illness, physical morbidity, and regular
medical emergencies) (C) and budget deficits result in
health staff cuts (C). These working conditions reduce
the capacity of health staff (MR), forcing them to
prioritise certain activities (MRE), such as dealing
with urgent conditions or emergencies, resulting in
testing clinics being delayed or cancelled and prisoners
not offered a test (O).
Insufficient staffing was most frequently reported in re-
sponse to the question “what other barriers did you
encounter when trying to complete an HIV test.. .at intake?”,
delivered to providers in a New York City Jail [47].
CMOc 5: Refusal to attend clinic
Prisoner agency also acted as a barrier to offering testing
under certain conditions [13, 44, 45].
When testing is conducted concurrently with other
prison activities (C), attendance at clinic becomes an
opportunity cost for the prisoner (MR). If health is a
lower priority, relative to the other activity (MRE),
the prisoner will not attend clinic (O).
Programme stakeholders reported prisoners refusing
to come to clinic because they were sleeping, watching
TV, playing sport, and attending gym [13, 44, 45].
CMOc 6: Rebooking prisoners
When prisoners failed to attend clinic or when clinics
were cancelled, health workers were required to rapidly
rebook them for testing [5, 11, 47, 56].
Budget deficits have led to health staff cuts (C). Stretched
health workers (C) that are required to re-book prisoners
(MR), prioritise medical emergencies and conducting
other tasks that require immediate attention (MRE),
further delaying the test offer (O). Overworked health
staff (C) may also forget to rebook a prisoner (MRE),
delaying the realisation of the test offer (O).
In high-turnover prison settings (C), a failure to rapidly
rebook a prisoner (MR), reduces the proportion of people
offered testing (O), as individuals may be released or
transferred by the time they are rebooked (C).
Test uptake
The proportion of prisoners that accept a test under
opt-out varied from 22 to 98% [13, 37–43]. There was a
notable lack of switching costs, with most programmes
simply requiring prisoners to verbally opt-out [8, 41, 48,
53]. Several costs and gains associated with opt-out BBV
testing within a prison context were also identified.
These were activated and modified depending on the
presence of certain programme resources.
CMOc 1: Confidentiality and stigma (loss aversion)
Confidentiality was a key resource for opt-out testing
programmes, as the enclosed environment of prison
amplifies fear of infectious disease amongst prisoners
and staff [51, 57, 58].
BBVs are stigmatised within the prison context (C).
Maintenance of confidentiality (MR) is therefore
crucial, as prisoners will feel safe (MRE) to share
personal information (O). If a prisoner distrusts prison
healthcare’s ability to maintain confidentiality (MR),
they may fear stigma (MRE), encouraging opt-out (O).
Officers view infectious prisoners as a personal risk
and may attempt to elicit confidential information
from health staff [51, 58]. The close contact between
staff and prisoners also means information can be
spread, both within and between staff and prisoner
groups: “Would I tell somebody else, a close friend, if
I knew they were in contact? Possibly yeah?” (prison
officer) [51]. Breaches in auditory and visual confiden-
tiality can also occur when conducting testing, as a
result of the confined environment, security require-
ments, and the increasing reliance on prisoners for
the maintenance of the prison environment [39, 47,
51, 57–61].
CMOc 2: Coping with a positive diagnosis (loss aversion)
Incarceration is stressful and the potential diagnosis of
an infectious disease, often perceived as terminal, can be
daunting [13, 38, 43, 54, 59, 60, 62–64].
BBVs are a situational concern for many people within
prison (C). The provision of supportive information
(e.g. treatment options, dispelling myths around
prognosis, and psychosocial support) (MR), reassures
a prisoner about coping if they test positive (MRE),
encouraging test uptake (O).
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Failure to provide supportive information (MR) can
leave people in prison feeling unable to cope with the
perceived burden associated with a positive diagnosis
(treatment, stigma, psychological distress, lifestyle
changes) (MRE), encouraging opt-out (O).
This was captured in quotes from health staff: “Some
clients will refuse to take the test out of fear of a positive
result” [38] and prisoners: “Er, I don’t know really,
[pause] er, I don’t really know, I mean, I think like I say,
I think people are just frightened ye na. People are fright-
ened to get the test ye na, thinking that it could be a
killer not knowing what, not knowing what it actually is,
what it actually does to you, I mean?” [60].
CMOc 3: Fear of an invasive procedure (loss aversion)
A fear of needles was frequently highlighted as a justifica-
tion for opt-out [12, 13, 40–42, 57, 64–66].
A proportion of prisoner’s fear needles (C). When
testing is conducted using a venous sample method
(MR), prisoners that are uncomfortable with the
method of blood acquisition (MRE) may opt-out (O).
This was captured in quotes from health workers: “.. .
I would say nine out of ten people say ‘I hate needles’
and tense up and freak out, and some people are really
upset by it” and “They were definitely more compliant
with it [oral testing]; they’re more willing to get it done
as opposed to getting their blood drawn” [41]. Less
invasive sample measures, such as DBST or oral testing,
may therefore help to minimise discomfort as a barrier
to testing.
CMOc 4: Institutional recommendations and trust (loss
aversion/recommendation)
Making testing the default option acts as an implicit
recommendation to test. Positive encouragement from
staff can also reinforce this message [44, 45].
Recommendations to test in circumstances of trust (C)
provide an institutional social pressure (MR) that
encourages an individual to comply with the perceived
positive action (MRE), encouraging test uptake (O).
However, institutional distrust is prevalent in prison (C).
Institutional social pressure (MR) can be perceived as a
coercive process of surveillance, triggering resistance from
the individual (MRE) and encouraging opt-out (O)
[59, 64, 67].
CMOc 5: Personal interpretation of risk (loss aversion)
Educational information on BBVs was an important resource
for opt-out programmes [13, 40, 47, 48, 57, 60, 63, 68].
Misconceptions around BBVs are common amongst
prisoners (C). Prisoners that have been informed about
modes of transmission and symptoms of the disease
(MR) are empowered (MRE) to accurately interpret
their risk of infection (O).
For prisoners that self-identify as “at risk” (C), testing
can be an opportunity to confirm serostatus (MR),
allowing the individual to either confront infection
(MRE) or be reassured by a negative result (MRE),
encouraging test uptake (O).
In the absence of supportive resources, people in
prison that see themselves as “at risk” may feel unable to
cope and instead opt-out (see CMOc 2 in this section)
[13, 38, 60].
Prisoners that interpret themselves as low risk (C), but
that face no other barriers to testing (MR), may still
seek reassurance (MRE), encouraging test uptake (O).
Prisoners that face other barriers to test uptake
(e.g. fears around confidentiality or dislike of test
method) (MR), may view testing as an unnecessary
burden (MRE) and opt-out of testing (O).
A range of articles reported issues with the delivery of edu-
cational information, with this stage of testing often being
truncated [13, 42, 43, 45–47, 54, 60]. In the absence of edu-
cational information, people in prison often inaccurately
interpreted themselves as low risk, due to a lack of symp-
toms, or because they had tested previously [13, 37, 38, 40,
42–44, 46, 50].
CMOc 6: Defaults and capacity to consent (cognitive
effort)
New prisoners often suffer from substance withdrawal, have
untreated mental health conditions, are physically exhausted,
and emotionally overwhelmed [11, 42, 43]. By making testing
the default option and offering testing soon after prison en-
trance, individuals may be tested without understanding
what it is they are testing for [8, 69].
New prisoners frequently lack capacity to provide
informed consent (C). If the health worker fails to
identify this and proceeds with an opt-out test offer
(MR), these individuals may misunderstand what is
taking place (MRE) or be unable to make an active
decision to opt-out (MRE), instead appearing to
comply with testing (O).
Grodensky et al. (2016) found that out of 871 patients
undergoing an opt-out HIV test, 103 were not aware of
being tested, 94 did not want to be tested, and 30 were not
aware they were tested and did not want a test.
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CMOc 7: Opt-out fidelity
The distinction between eliciting consent in an opt-in,
opt-out, or mandatory manner is nuanced and diffi-
cult to operationalise in practice [5, 8, 48, 70]. The
review highlighted variation in the delivery of an
opt-out test, which may partially account for variation
in test uptake.
If programme implementers misinterpret how to
deliver an opt-out test (C), training and scripts pro-
vided to health workers (MR) will encourage them to
comply (MRE) with the delivery of either an opt-in (O)
or mandatory (O) test offer.
An opt-out test offer is not the norm (C). When health
workers have little training, and no standard script
(MR), the meaning of opt-out may be misinterpreted
(MRE) resulting in either opt-in (O) or mandatory (O)
test offers. The way testing is offered, when there is no
standard script (MR), can also morph with each en-
counter, with rapport (C), situational distractions (C)
and fatigue (C) all potentially influencing test
delivery (O).
A survey conducted by Rosen et al. (2015) as part of an
opt-out testing programme that had a 95% test uptake [8,
48], found that less than 40% of prisoners identified test-
ing as voluntary, which was attributed to an ambiguous
consent process and widespread failure of nurses to
mention a prisoner’s right to decline the test [8].
Discussion
60 articles were synthesised to provide CMOcs explain-
ing how, why, for whom, and under what conditions
opt-out programmes for HIV, HCV, and HBV might
generate a high proportion of test offers and test uptake.
The unstructured search conducted during phase one,
identified a number of articles highlighting that the De-
fault Effect underpins “opt-out”. It was notable that no
documents supplied by the expert panel during phase
one and none of the articles from phase two mentioned
Nudge Theory or the Default Effect as a consideration in
the development or subsequent evaluation of opt-out
BBV testing within prison [35]. It appears that these
concepts, which underpin the intervention, have been
widely forgotten, as “opt-out” is reproduced by stake-
holders in different contexts [71].
Offered a test
Implementation factors were found to significantly limit
the proportion of prison intake offered testing [8, 37, 38,
45, 46, 48]. Programmes that implement testing early
can increase the proportion of people offered a test (par-
ticularly within high-turnover prisons), but may be
inhibited by greater volumes of individuals unable to
provide informed consent [42, 43]. Further work is re-
quired to determine whether the timing of the test offer
has an impact on test uptake [42, 43]. Where possible,
prisons with a short average incarceration length should
look to conduct testing on the first night, during second
reception, and at any appropriate subsequent clinics, in
order to balance risk of release and capacity to consent
[42, 43, 56].
It was noted that testing was also subject to a range of
barriers, which limited provider access to prisoners. These
barriers further delayed the realisation of the test offer and
operated in causal chains [72], with several intermediate
outcomes leading to the final outcome of a failed test offer
(example in Fig. 5). Even when programmes specify an ap-
propriate period within which the test offer should occur,
given the average incarceration length of their population,
it is likely that a proportion of prisoners will be engaged
much later, all the time risking release.
The operational capacity of prison officers and health
workers were reoccurring contextual features within
these causal chains [5, 11, 47, 56]. Historic de-valuation
of prisoner well-being is often enacted through budget
cuts to the prison estate, reducing the operational cap-
acity of the staff [73]. Greater emphasis should be placed
on prisoner well-being via appropriate funding of the
prison estate, both out of public health and ethical
necessity [74].
More immediate options for opt-out programmes strug-
gling with engagement could include: complimentary
sub-interventions to foster collaboration between health
workers and prison officers, educational events in prison to
encourage prioritisation of the programme, and incentivis-
ing clinic attendance for prisoners (e.g. by making it a com-
pulsory pre-cursor for gym attendance) [44–46, 51, 55].
Test uptake
Varying numbers of people offered a test were found to
opt-out [13, 37–43]. The lack of compelling switching
costs, implemented by many opt-out programmes
reviewed, may be explained by the absence of Nudge
Theory in programme conception. Much of the power
of opt-out strategies, when used in sectors like market-
ing, comes from “sleight of hand” tactics (e.g. using
miniature font) [4, 34, 35]. Those implementing health-
care programmes do not have the luxury of such tactics
and therefore need to optimise their use of defaults,
whilst working within the ethical paradigm of informed
consent [4, 34]. Programmes struggling with test uptake
could therefore consider piloting minor switching costs
(e.g. an opt-out justification form that prisoners are
asked to complete [44]), although caution should be
exercised to ensure that this does not become coercive.
Francis-Graham et al. BMC Health Services Research          (2019) 19:152 Page 14 of 18
The review also highlighted ethical considerations,
related to the exploitation of individual bias not to
expend cognitive effort under opt-out [4, 35]. Given the
vulnerability of the population group, providers need to
be vigilant of capacity to consent when offering testing,
ensuring those that do not make an active decision
about testing, do so from a lack of preference as
opposed to inability as a result of substance withdrawal
or mental illness [35, 42, 43].
Prisoners’ decision to accept testing or opt-out was
however found to be influenced by a range of costs and
benefits related to testing for BBVs. Although loss aver-
sion suggests that this weighting should be in favour of
testing, significant costs were identified, which provided
a strong counterbalancing force (Fig. 6) [34, 35].
Resources such as confidentiality, education, trust,
psychosocial support, and less invasive sample methods
were found to be important at mitigating testing costs
and encouraging test uptake (Fig. 6). These resources
were frequently built into the opt-out programmes
reviewed [5, 11, 27]. For programmes that experienced
issues with the implementation of one or several of these
resources, further research is required to unpick why
these different programme resources were unsuccessfully
realised within different prison contexts.
Finally, refined theory highlighted challenges to the
fidelity of opt-out, which stemmed from the conceptu-
alisation of the offer by programme implementers,
misinterpretation by those delivering the test offer,
and/or due to contextual pressures [5, 8, 48, 70]. The
need to acquire consent can naturally lead to asking a
person if they would “like to test” [42, 43], failing to
fully adhere with principles of opt-out and potentially
limiting uptake [7, 13]. However, not informing a pris-
oner that they have the right to decline, given the pu-
nitive context, borders on a mandatory approach [75,
76] and raises ethical questions if prisoner’s interpret
it as such [8, 48].
Further work is required to determine what constitutes
an opt-out offer and how adherence to opt-out can be
ensured in practice. However, a written set of words for
health workers to use when offering testing, could help
to standardise the process [5, 7, 8, 48, 70]. A set of
words conceived by NHSE and PHE commissioners, but
not implemented during the English service reconfigur-
ation, were synthesised with findings from this review to
develop a recommended set of words that were then
shared with the London BBV Core Steering Group
(Additional file 6).
Limitations
Much of the empirical data came from opt-out HIV test-
ing conducted within US prisons, potentially limiting the
applicability of refined theories to the English prison
context, where HIV, HCV, and HBV are tested for
together, commonly using DBST. However, validation
with English stakeholders, as well as observation of
opt-out training and testing in two English prisons, was
undertaken in an attempt to ensure relevance [16].
Many articles did not include information about the
wording of the offer, meaning reviewers were forced to
assume that testing really was, for the most part, offered
as opt-out [37–41, 46, 53, 55, 67, 77]. It is important that
details, preferably a standard quote, for the process of
gaining consent to test, are presented, providing trans-
parency and allowing for an assessment of the true na-
ture of the offer process [7, 8, 42, 43, 48].
The reviewers were also heavily reliant on author justi-
fications for failure to offer testing and prisoner opt-out.
Qualitative insights into the reasoning processes of
different prison stakeholders were scarce and therefore
often inferred. In all reviews that utilise realist synthesis
methodology, there will be some judgement involved
when making inferences between the data found in in-
cluded studies [18, 78], however further qualitative
Fig. 5 Example causal chain, with various intermediary outcomes that lead to the final outcome of public health interest. Each intermediary outcome
forms the context of a subsequent programme theory. This casual chain operates between two spheres of context, detailed in Fig. 3 (the “Specific
prison Context” and the “Programme implementation context”)
Francis-Graham et al. BMC Health Services Research          (2019) 19:152 Page 15 of 18
research is required to provide greater insight into the
decision-making process of relevant stakeholders.
The framework sketched out in this review is therefore
intended to provide a starting point on which to build
our understanding of opt-out BBV programmes in
prison [71]. The CMOcs presented are falsifiable and
require further refinement using primary data [71]. To
help enable this process, and in line with best practice,
the authors have attempted to maximise the transpar-
ency of the review process [78].
Conclusion
Opt-out testing programmes for BBVs within prison have
been found to increase test uptake, however evaluative work
has reported a high degree of variability in key outcomes.
This synthesis highlighted important implementation consid-
erations, which influence the effectiveness of these
programmes. The fidelity of opt-out was also questionable,
both at the programme level and because of inter and intra
health worker variability in the way testing is offered.
Programme implementers are encouraged to utilise
Nudge Theory within their opt-out BBV test design, to
take full advantage of the Default Effect for public health
benefit. They are also encouraged to think carefully
about the timing of the test offer, work with prison
authorities to overcome logistical barriers to accessing
prisoners, explore ways of enhancing the fidelity of an
opt-out offer, and ensure the realisation of key
programme resources that can mitigate testing costs.
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